Laurent BRONES

企业代表, 法国

The Changing Face of the Asia-Pacific Aesthetic Market

医疗经营管理
针剂注射
激光, 光声电仪 & 非手术塑体

阅读了2 分钟

Laurent Brones, Business Development Manager at Symatese, France, reveals the latest market data for different aesthetic treatments.

Lectures are performed during the IMCAS ASIA TRIBUNE regarding the injectable market, which is the largest market segment in aesthetics, valued at USD 3,1 billion, followed by the laser & EBD market valued at USD 2,4 billion worldwide (source: Medical Insight). Note that the cosmeuceutical and breast implant markets respectively represent USD 1,7 and 1,1 billion.

Sana Siddiqui Syed, Director Global Consulting Services at DRG presents the latest data on the injectable market (toxins and dermal fillers).

Facial injectables

The global facial injectables market is booming and massive growth in the Asia-Pacific region is a substantial contributor to this industry-wide success. APAC now represents 31% of this market and will grow faster than other territories to achieve 39% of the worldwide market while the current (USD 1,7 billion in 2020) biggest North American territory will decrease from 43% to 39%. The reasons for this booming of the APAC market are an underpenetrated market compared to other territories – as only 0,3% access treatments while in Europe for example 1,9% perform treatment – and the fact that more young patients are seeking anti-aging techniques. The biggest countries in descending order for APAC are China, Japan, Korea, Australia, India and Taiwan. The market barriers include stricter and lengthy regulatory approval processes in north Asian countries and Australia, and counterfeits products, which also affect the image of those treatments and high procedure costs.

Laser & EBD market

Robert Ruck, Executive Vice President, APAC at SYNERON CANDELA presents the latest data on the laser & EBD market. APAC is experiencing the biggest growth at +13% per year, whereas other territories like EU or North America grow at +10%. APAC is an heterogenic area where product registration, skin types and economy vary per country, consequently making APAC a challenging territory. Foreign exchange and copycats also affect this market. Regarding the most popular aesthetic treatments, Hair Removal is still going strong while Body Shape is continuously getting more and more interest together with anti-aging treatments.

According to the IMCAS INDUSTRY TRIBUNE market analysis performed during the last IMCAS congress in January, Injectable, laser & EBD, cosmeceuticals and breast implants respectively represent 53%, 25%, 17%, 5% of the total APAC market, demonstrating the success of the products and the high potential for breast augmentation procedures and the development of more invasive techniques.

Tagged: 医疗经营管理, 针剂注射, 激光, 光声电仪 & 非手术塑体

Share this article on

关于作者

Laurent BRONES

企业代表, 法国

评论

Connect with the IMCAS community !

有关发表

Published on 2022年 10月 21日

The Injector’s Role as Conductor In the Management of Facial Expressive Mal-Orchestration

Published on 2019年 4月 24日

Lip Fillers: How to Use Fillers to the Most Natural, Youthful Appearance

Published on 2025年 4月 3日

Advancing Thread Lifts: Insights from Dr. Paisal Rummaneethorn & Dr. Amit Luthra

发现 IMCAS Academy

关注 IMCAS

需要帮助吗?

隐私政策 法律信息
© 2026 IMCAS - 国际医学美容抗衰老大师课程 版权所有。
处理中,请稍候...

错误

请填写所有必填字段。以下是缺失的字段: